Byotrol plc
Byotrol plc
('Byotrol' or 'the Company')
The Directors of Byotrol, the anti-microbial technology company, announce that
the Company has changed its accounting reference date from 30 June to 31 March.
Accordingly, the first set of results for Byotrol, whose shares were admitted to
trading on the AIM Market on 6 July 2005, will be from 17th May 2005 to 30th
September 2005 and announced in early December 2005.
Financial enquiries to:
Nick Rodgers or Oli Rayner
Merchant Capital
0207 332 2200
Media calls to:
Jim Rothnie
McCann Erickson PR
T: 01625 822540
E: jim.rothnie@europe.mccann.com
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.